S&P 500   3,365.32 (-0.44%)
DOW   29,180.46 (-0.74%)
QQQ   234.30 (-0.14%)
AAPL   317.82 (-2.19%)
FB   217.40 (+1.50%)
MSFT   186.88 (+0.83%)
GOOGL   1,518.93 (+0.01%)
AMZN   2,159.24 (+1.14%)
CGC   22.67 (+2.44%)
NVDA   293.14 (+1.16%)
BABA   219.27 (-0.16%)
MU   57.74 (-1.30%)
GE   12.72 (-0.93%)
TSLA   849.69 (+6.21%)
AMD   57.53 (+4.00%)
T   38.21 (-0.10%)
F   8.02 (-0.99%)
BAC   34.24 (-1.75%)
GILD   66.89 (-0.99%)
S&P 500   3,365.32 (-0.44%)
DOW   29,180.46 (-0.74%)
QQQ   234.30 (-0.14%)
AAPL   317.82 (-2.19%)
FB   217.40 (+1.50%)
MSFT   186.88 (+0.83%)
GOOGL   1,518.93 (+0.01%)
AMZN   2,159.24 (+1.14%)
CGC   22.67 (+2.44%)
NVDA   293.14 (+1.16%)
BABA   219.27 (-0.16%)
MU   57.74 (-1.30%)
GE   12.72 (-0.93%)
TSLA   849.69 (+6.21%)
AMD   57.53 (+4.00%)
T   38.21 (-0.10%)
F   8.02 (-0.99%)
BAC   34.24 (-1.75%)
GILD   66.89 (-0.99%)
S&P 500   3,365.32 (-0.44%)
DOW   29,180.46 (-0.74%)
QQQ   234.30 (-0.14%)
AAPL   317.82 (-2.19%)
FB   217.40 (+1.50%)
MSFT   186.88 (+0.83%)
GOOGL   1,518.93 (+0.01%)
AMZN   2,159.24 (+1.14%)
CGC   22.67 (+2.44%)
NVDA   293.14 (+1.16%)
BABA   219.27 (-0.16%)
MU   57.74 (-1.30%)
GE   12.72 (-0.93%)
TSLA   849.69 (+6.21%)
AMD   57.53 (+4.00%)
T   38.21 (-0.10%)
F   8.02 (-0.99%)
BAC   34.24 (-1.75%)
GILD   66.89 (-0.99%)
S&P 500   3,365.32 (-0.44%)
DOW   29,180.46 (-0.74%)
QQQ   234.30 (-0.14%)
AAPL   317.82 (-2.19%)
FB   217.40 (+1.50%)
MSFT   186.88 (+0.83%)
GOOGL   1,518.93 (+0.01%)
AMZN   2,159.24 (+1.14%)
CGC   22.67 (+2.44%)
NVDA   293.14 (+1.16%)
BABA   219.27 (-0.16%)
MU   57.74 (-1.30%)
GE   12.72 (-0.93%)
TSLA   849.69 (+6.21%)
AMD   57.53 (+4.00%)
T   38.21 (-0.10%)
F   8.02 (-0.99%)
BAC   34.24 (-1.75%)
GILD   66.89 (-0.99%)
Log in

Miragen Therapeutics News Headlines (NASDAQ:MGEN)

$0.80
+0.10 (+14.29 %)
(As of 02/18/2020 02:01 PM ET)
Today's Range
$0.70
Now: $0.80
$0.85
50-Day Range
$0.47
MA: $0.88
$2.04
52-Week Range
$0.44
Now: $0.80
$3.80
Volume3.14 million shs
Average Volume6.19 million shs
Market Capitalization$25.43 million
P/E RatioN/A
Dividend YieldN/A
Beta0.98

Headlines

Miragen Therapeutics (NASDAQ MGEN) News Headlines

Source:
DateHeadline
Has Signal Genetics (MGEN) Outpaced Other Medical Stocks This Year?Has Signal Genetics (MGEN) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - February 14 at 2:22 PM
Short Interest in Miragen Therapeutics Inc (NASDAQ:MGEN) Drops By 22.0%Short Interest in Miragen Therapeutics Inc (NASDAQ:MGEN) Drops By 22.0%
www.americanbankingnews.com - February 12 at 7:03 PM
10 Biotechnology Stocks Moving In Fridays Pre-Market Session10 Biotechnology Stocks Moving In Friday's Pre-Market Session
www.benzinga.com - February 7 at 9:46 AM
MiRagen down 24% after pricing equity offeringMiRagen down 24% after pricing equity offering
seekingalpha.com - February 7 at 9:46 AM
miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common StockmiRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - February 7 at 9:46 AM
Miragen Therapeutics Inc (NASDAQ:MGEN) Expected to Announce Quarterly Sales of $970,000.00Miragen Therapeutics Inc (NASDAQ:MGEN) Expected to Announce Quarterly Sales of $970,000.00
www.americanbankingnews.com - February 7 at 5:25 AM
miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common StockmiRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - February 6 at 5:19 PM
 Brokerages Expect Miragen Therapeutics Inc (NASDAQ:MGEN) to Post -$0.25 EPS Brokerages Expect Miragen Therapeutics Inc (NASDAQ:MGEN) to Post -$0.25 EPS
www.americanbankingnews.com - February 5 at 6:46 AM
Miragen Therapeutics Inc (NASDAQ:MGEN) Short Interest UpdateMiragen Therapeutics Inc (NASDAQ:MGEN) Short Interest Update
www.americanbankingnews.com - January 31 at 9:24 AM
Miragen Therapeutics (MGEN) "Buy" Rating Reiterated at WedbushMiragen Therapeutics' (MGEN) "Buy" Rating Reiterated at Wedbush
www.americanbankingnews.com - January 30 at 4:25 PM
Thinking about buying stock in Beyond Meat, Miragen Therapeutics, Microsoft, Nio, or Sunrun?Thinking about buying stock in Beyond Meat, Miragen Therapeutics, Microsoft, Nio, or Sunrun?
www.marketwatch.com - January 30 at 1:23 PM
Cobomarsen data stokes miRagen; up 34% premarketCobomarsen data stokes miRagen; up 34% premarket
seekingalpha.com - January 30 at 1:23 PM
32 Stocks Moving in Thursdays Pre-Market Session32 Stocks Moving in Thursday's Pre-Market Session
www.msn.com - January 30 at 8:22 AM
miRagen Therapeutics Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual DiseasemiRagen Therapeutics Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual Disease
finance.yahoo.com - January 30 at 8:22 AM
Wedbush Reaffirms Buy Rating for Miragen Therapeutics (NASDAQ:MGEN)Wedbush Reaffirms Buy Rating for Miragen Therapeutics (NASDAQ:MGEN)
www.americanbankingnews.com - January 24 at 12:03 PM
miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming ConferencesmiRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming Conferences
finance.yahoo.com - January 23 at 8:34 AM
13 Healthcare Stocks Moving In Thursdays Pre-Market Session13 Healthcare Stocks Moving In Thursday's Pre-Market Session
www.msn.com - December 13 at 12:21 AM
BRIEF-Miragen Announces Reduction In Work Force As Part Of Strategic Shift And Cost RealignmentBRIEF-Miragen Announces Reduction In Work Force As Part Of Strategic Shift And Cost Realignment
www.msn.com - December 11 at 10:30 PM
miRagen Announces Major Changes to Company’s StrategymiRagen Announces Major Changes to Company’s Strategy
finance.yahoo.com - December 11 at 5:29 PM
miRagen to Present at the Evercore ISI HealthCONx Conference 2019miRagen to Present at the Evercore ISI HealthCONx Conference 2019
finance.yahoo.com - November 26 at 8:40 AM
Could Miragen Therapeutics, Inc.'s (NASDAQ:MGEN) Investor Composition Influence The Stock Price?Could Miragen Therapeutics, Inc.'s (NASDAQ:MGEN) Investor Composition Influence The Stock Price?
finance.yahoo.com - November 12 at 6:26 PM
BRIEF-miRagen Therapeutics Reports Q3 Loss Per Share Of $0.36BRIEF-miRagen Therapeutics Reports Q3 Loss Per Share Of $0.36
www.msn.com - November 7 at 11:16 PM
Signal Genetics, Inc. (MGEN) Reports Q3 Loss, Lags Revenue EstimatesSignal Genetics, Inc. (MGEN) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 7 at 11:16 PM
miRagen Reports Third Quarter 2019 Results and Provides Corporate UpdatemiRagen Reports Third Quarter 2019 Results and Provides Corporate Update
finance.yahoo.com - November 7 at 6:15 PM
Earnings Preview: Signal Genetics, Inc. (MGEN) Q3 Earnings Expected to DeclineEarnings Preview: Signal Genetics, Inc. (MGEN) Q3 Earnings Expected to Decline
finance.yahoo.com - October 31 at 2:48 PM
miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference TodaymiRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference Today
finance.yahoo.com - October 28 at 12:47 PM
miRagen Therapeutics to Report Third Quarter 2019 Financial Results and Host a Conference CallmiRagen Therapeutics to Report Third Quarter 2019 Financial Results and Host a Conference Call
finance.yahoo.com - October 22 at 8:34 AM
miRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel GrowthmiRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel Growth
finance.yahoo.com - October 16 at 9:11 AM
MGEN.A - Miragen Therapeutics Inc Profile | ReutersMGEN.A - Miragen Therapeutics Inc Profile | Reuters
www.reuters.com - October 8 at 12:40 PM
miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare ConferencemiRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare Conference
finance.yahoo.com - August 15 at 11:06 AM
miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare ConferencemiRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference
finance.yahoo.com - August 12 at 1:27 PM
42 Healthcare Stocks Moving In Wednesdays After-Market Session42 Healthcare Stocks Moving In Wednesday's After-Market Session
www.msn.com - August 8 at 8:24 PM
miRagen Therapeutics (MGEN) CEO Bill Marshall on Q2 2019 Results - Earnings Call TranscriptmiRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 12:52 PM
Signal Genetics, Inc. (MGEN) Reports Q2 Loss, Tops Revenue EstimatesSignal Genetics, Inc. (MGEN) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 8 at 12:52 PM
miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate RestructuringmiRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring
finance.yahoo.com - August 7 at 8:29 PM
Miragen down 20% ahead of Q2 reportMiragen down 20% ahead of Q2 report
seekingalpha.com - August 6 at 3:17 PM
Analysts Estimate Signal Genetics, Inc. (MGEN) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Signal Genetics, Inc. (MGEN) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - July 31 at 11:21 AM
Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7thMiragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
finance.yahoo.com - July 24 at 3:29 PM
Some Miragen Therapeutics (NASDAQ:MGEN) Shareholders Have Copped A Big 66% Share Price DropSome Miragen Therapeutics (NASDAQ:MGEN) Shareholders Have Copped A Big 66% Share Price Drop
finance.yahoo.com - June 21 at 3:00 PM
Miragen Therapeutics (MGEN) Presents At 2019 Jefferies Global Healthcare Conference - SlideshowMiragen Therapeutics (MGEN) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - June 6 at 3:13 PM
miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare ConferencemiRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 29 at 5:11 AM
miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International ConferencemiRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference
finance.yahoo.com - May 21 at 3:08 PM
miRagen Therapeutics, Inc. (MGEN) CEO Bill Marshall on Q1 2019 Results - Earnings Call TranscriptmiRagen Therapeutics, Inc. (MGEN) CEO Bill Marshall on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 5:14 AM
miRagen Announces First Quarter 2019 Financial Results and Provides Corporate UpdatemiRagen Announces First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 9 at 5:07 AM
Signal Genetics, Inc. (MGEN) Reports Q1 Loss, Misses Revenue EstimatesSignal Genetics, Inc. (MGEN) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 9 at 5:07 AM
Earnings Preview: Signal Genetics, Inc. (MGEN) Q1 Earnings Expected to DeclineEarnings Preview: Signal Genetics, Inc. (MGEN) Q1 Earnings Expected to Decline
finance.yahoo.com - May 1 at 3:07 PM
MiRagen up 8% premarket on encouraging remlarsen dataMiRagen up 8% premarket on encouraging remlarsen data
seekingalpha.com - April 29 at 3:12 PM
miRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO MeetingmiRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO Meeting
finance.yahoo.com - April 29 at 3:11 PM
Can We See Significant Institutional Ownership On The Miragen Therapeutics, Inc. (NASDAQ:MGEN) Share Register?Can We See Significant Institutional Ownership On The Miragen Therapeutics, Inc. (NASDAQ:MGEN) Share Register?
finance.yahoo.com - April 28 at 3:09 PM
MiRagen up 19% premarket in encouraging cobomarsen dataMiRagen up 19% premarket in encouraging cobomarsen data
seekingalpha.com - April 26 at 3:13 PM
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel